Cargando…

Studying SARS-CoV-2 vaccine hesitancy among health professionals in Tunisia

BACKGROUND: People's lives were seriously affected by the emergence and the spread of the COVID-19 disease. Several vaccines were developed in record time to overcome this pandemic. However, putting an end to this public health problem requires substantial vaccination coverage rate. This latter...

Descripción completa

Detalles Bibliográficos
Autores principales: Zammit, Nawel, Gueder, Amani El, Brahem, Aïcha, Ayouni, Imen, Ghammam, Rim, Fredj, Sihem Ben, Sridi, Chaima, Chouchene, Asma, Kalboussi, Houda, Maalel, Olfa El, Chatti, Souhaeil, Maatoug, Jihene, Ghannem, Hassen, Mrizak, Néjib
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9004208/
https://www.ncbi.nlm.nih.gov/pubmed/35413911
http://dx.doi.org/10.1186/s12913-022-07803-y
_version_ 1784686240395689984
author Zammit, Nawel
Gueder, Amani El
Brahem, Aïcha
Ayouni, Imen
Ghammam, Rim
Fredj, Sihem Ben
Sridi, Chaima
Chouchene, Asma
Kalboussi, Houda
Maalel, Olfa El
Chatti, Souhaeil
Maatoug, Jihene
Ghannem, Hassen
Mrizak, Néjib
author_facet Zammit, Nawel
Gueder, Amani El
Brahem, Aïcha
Ayouni, Imen
Ghammam, Rim
Fredj, Sihem Ben
Sridi, Chaima
Chouchene, Asma
Kalboussi, Houda
Maalel, Olfa El
Chatti, Souhaeil
Maatoug, Jihene
Ghannem, Hassen
Mrizak, Néjib
author_sort Zammit, Nawel
collection PubMed
description BACKGROUND: People's lives were seriously affected by the emergence and the spread of the COVID-19 disease. Several vaccines were developed in record time to overcome this pandemic. However, putting an end to this public health problem requires substantial vaccination coverage rate. This latter depends on the acceptance of these vaccines especially by health professionals; the leaders of the current war against COVID-19. In fact, they have a central role in promoting vaccination against the SARS-CoV-2. In the developed countries, hesitancy rates towards these vaccines among health professionals vary from 4.3% to 72%. In the developing countries, few studies focused on this issue. OBJECTIVE: To estimate the prevalence and the predictors of SARS-CoV-2 vaccine hesitancy among the Tunisian health professionals. METHODS: A cross-sectional study was led online between the 7th and the 21th of January 2021 among Tunisian health professionals. At least 460 participants were required. Snowball sampling method served to recruit participants. Data were collected using a pre-established and pre-tested questionnaire recorded in a free Google form. The link of the questionnaire was disseminated online to be self-administered anonymously to the participants. The generated online Google Sheet was uploaded and exported to SPSS software for analysis. RESULTS: Of the 546 responses, 493 were retained. The mean age of participants was 37.4 (± 9.5) years. Females represented 70.2% of participants. Social media represented the most frequently used source of information about COVID-19. The prevalence of SARS-CoV-2 vaccine hesitancy among participants was 51.9% (95% CI(:) 47.5–56.3)). Female sex, working far from the capital and having concerns about the vaccines components predicted more hesitancy among participants. In contrast, the use of the national COVID-19 information website predicted less hesitancy among them. CONCLUSIONS: The current Tunisian communication plan about COVID-19 vaccines must be reinforced. Social media represent a cost effective communication channel that can serve to reassure Tunisian health professionals regarding the safety of COVID-19 vaccines. Special interest should be paid to females, paramedical professionals and those working far from the capital.
format Online
Article
Text
id pubmed-9004208
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-90042082022-04-12 Studying SARS-CoV-2 vaccine hesitancy among health professionals in Tunisia Zammit, Nawel Gueder, Amani El Brahem, Aïcha Ayouni, Imen Ghammam, Rim Fredj, Sihem Ben Sridi, Chaima Chouchene, Asma Kalboussi, Houda Maalel, Olfa El Chatti, Souhaeil Maatoug, Jihene Ghannem, Hassen Mrizak, Néjib BMC Health Serv Res Research BACKGROUND: People's lives were seriously affected by the emergence and the spread of the COVID-19 disease. Several vaccines were developed in record time to overcome this pandemic. However, putting an end to this public health problem requires substantial vaccination coverage rate. This latter depends on the acceptance of these vaccines especially by health professionals; the leaders of the current war against COVID-19. In fact, they have a central role in promoting vaccination against the SARS-CoV-2. In the developed countries, hesitancy rates towards these vaccines among health professionals vary from 4.3% to 72%. In the developing countries, few studies focused on this issue. OBJECTIVE: To estimate the prevalence and the predictors of SARS-CoV-2 vaccine hesitancy among the Tunisian health professionals. METHODS: A cross-sectional study was led online between the 7th and the 21th of January 2021 among Tunisian health professionals. At least 460 participants were required. Snowball sampling method served to recruit participants. Data were collected using a pre-established and pre-tested questionnaire recorded in a free Google form. The link of the questionnaire was disseminated online to be self-administered anonymously to the participants. The generated online Google Sheet was uploaded and exported to SPSS software for analysis. RESULTS: Of the 546 responses, 493 were retained. The mean age of participants was 37.4 (± 9.5) years. Females represented 70.2% of participants. Social media represented the most frequently used source of information about COVID-19. The prevalence of SARS-CoV-2 vaccine hesitancy among participants was 51.9% (95% CI(:) 47.5–56.3)). Female sex, working far from the capital and having concerns about the vaccines components predicted more hesitancy among participants. In contrast, the use of the national COVID-19 information website predicted less hesitancy among them. CONCLUSIONS: The current Tunisian communication plan about COVID-19 vaccines must be reinforced. Social media represent a cost effective communication channel that can serve to reassure Tunisian health professionals regarding the safety of COVID-19 vaccines. Special interest should be paid to females, paramedical professionals and those working far from the capital. BioMed Central 2022-04-12 /pmc/articles/PMC9004208/ /pubmed/35413911 http://dx.doi.org/10.1186/s12913-022-07803-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Zammit, Nawel
Gueder, Amani El
Brahem, Aïcha
Ayouni, Imen
Ghammam, Rim
Fredj, Sihem Ben
Sridi, Chaima
Chouchene, Asma
Kalboussi, Houda
Maalel, Olfa El
Chatti, Souhaeil
Maatoug, Jihene
Ghannem, Hassen
Mrizak, Néjib
Studying SARS-CoV-2 vaccine hesitancy among health professionals in Tunisia
title Studying SARS-CoV-2 vaccine hesitancy among health professionals in Tunisia
title_full Studying SARS-CoV-2 vaccine hesitancy among health professionals in Tunisia
title_fullStr Studying SARS-CoV-2 vaccine hesitancy among health professionals in Tunisia
title_full_unstemmed Studying SARS-CoV-2 vaccine hesitancy among health professionals in Tunisia
title_short Studying SARS-CoV-2 vaccine hesitancy among health professionals in Tunisia
title_sort studying sars-cov-2 vaccine hesitancy among health professionals in tunisia
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9004208/
https://www.ncbi.nlm.nih.gov/pubmed/35413911
http://dx.doi.org/10.1186/s12913-022-07803-y
work_keys_str_mv AT zammitnawel studyingsarscov2vaccinehesitancyamonghealthprofessionalsintunisia
AT guederamaniel studyingsarscov2vaccinehesitancyamonghealthprofessionalsintunisia
AT brahemaicha studyingsarscov2vaccinehesitancyamonghealthprofessionalsintunisia
AT ayouniimen studyingsarscov2vaccinehesitancyamonghealthprofessionalsintunisia
AT ghammamrim studyingsarscov2vaccinehesitancyamonghealthprofessionalsintunisia
AT fredjsihemben studyingsarscov2vaccinehesitancyamonghealthprofessionalsintunisia
AT sridichaima studyingsarscov2vaccinehesitancyamonghealthprofessionalsintunisia
AT choucheneasma studyingsarscov2vaccinehesitancyamonghealthprofessionalsintunisia
AT kalboussihouda studyingsarscov2vaccinehesitancyamonghealthprofessionalsintunisia
AT maalelolfael studyingsarscov2vaccinehesitancyamonghealthprofessionalsintunisia
AT chattisouhaeil studyingsarscov2vaccinehesitancyamonghealthprofessionalsintunisia
AT maatougjihene studyingsarscov2vaccinehesitancyamonghealthprofessionalsintunisia
AT ghannemhassen studyingsarscov2vaccinehesitancyamonghealthprofessionalsintunisia
AT mrizaknejib studyingsarscov2vaccinehesitancyamonghealthprofessionalsintunisia